1. Home
  2. VALU vs AVXL Comparison

VALU vs AVXL Comparison

Compare VALU & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Value Line Inc.

VALU

Value Line Inc.

N/A

Current Price

$33.14

Market Cap

311.5M

Sector

Finance

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$2.68

Market Cap

251.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALU
AVXL
Founded
1931
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.5M
251.1M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
VALU
AVXL
Price
$33.14
$2.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
1.0K
879.2K
Earning Date
03-16-2026
05-08-2026
Dividend Yield
3.72%
N/A
EPS Growth
8.91
N/A
EPS
1.92
N/A
Revenue
$36,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.34
N/A
Revenue Growth
1.08
N/A
52 Week Low
$32.73
$2.61
52 Week High
$40.50
$13.99

Technical Indicators

Market Signals
Indicator
VALU
AVXL
Relative Strength Index (RSI) 38.46 31.88
Support Level N/A $2.61
Resistance Level $38.26 $3.50
Average True Range (ATR) 0.47 0.17
MACD -0.04 -0.04
Stochastic Oscillator 17.57 5.30

Price Performance

Historical Comparison
VALU
AVXL

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: